New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...
The Amazing Times on MSN3d
Five Common Medications That May Increase Your Risk of DementiaDementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...
Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the ...
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively ...
A doctor who punched a dementia patient in the head and pushed his head into a pillow, has been erased from the medical ...
Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... s disease ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has accepted BioArctic's partner Eisai's Biologics License Application (BLA) for Leqembi ...
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
The risk of developing dementia may be much higher than previously thought, a study published Monday in the journal Nature ...
The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback